BAMCO INC /NY/ - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 159 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2021. The put-call ratio across all filers is 3.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
BAMCO INC /NY/ ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q1 2021$10,477,000
+7.9%
373,5000.0%0.03%
+8.3%
Q4 2020$9,711,000
-21.7%
373,500
+12.0%
0.02%
-36.8%
Q3 2020$12,396,000
-16.3%
333,500
+15.6%
0.04%
-29.6%
Q2 2020$14,803,000
+149.1%
288,500
+53.1%
0.05%
+86.2%
Q1 2020$5,943,000
-47.1%
188,5000.0%0.03%
-32.6%
Q4 2019$11,240,000
+62.7%
188,5000.0%0.04%
+53.6%
Q3 2019$6,910,000
-21.2%
188,5000.0%0.03%
-20.0%
Q2 2019$8,769,000
+19.0%
188,500
+2.7%
0.04%
+12.9%
Q1 2019$7,368,000
+60.2%
183,500
+83.5%
0.03%
+34.8%
Q4 2018$4,600,000
+3.7%
100,0000.0%0.02%
+27.8%
Q3 2018$4,437,000
+612.2%
100,000
+528.9%
0.02%
+500.0%
Q2 2018$623,000
-65.4%
15,900
-36.1%
0.00%
-62.5%
Q1 2018$1,801,000
+112.1%
24,900
+93.0%
0.01%
+100.0%
Q4 2017$849,000
+212.1%
12,900
+5.7%
0.00%
+300.0%
Q4 2015$272,000
-5.6%
12,2000.0%0.00%0.0%
Q3 2015$288,000
-71.1%
12,2000.0%0.00%
-75.0%
Q2 2015$997,000
-56.1%
12,200
-50.2%
0.00%
-55.6%
Q1 2015$2,269,000
+59.5%
24,500
-30.4%
0.01%
+50.0%
Q4 2014$1,423,000
+142.4%
35,200
+46.7%
0.01%
+200.0%
Q3 2014$587,00024,0000.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q1 2021
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$20,735,0008.65%
Altium Capital Management LP 2,496,524$11,584,0003.88%
Deep Track Capital, LP 6,000,000$27,840,0001.78%
Paradigm Biocapital Advisors LP 1,157,246$5,370,0001.42%
Monaco Asset Management SAM 419,262$1,945,0000.77%
Rhenman & Partners Asset Management AB 981,582$4,555,0000.45%
PLATINUM INVESTMENT MANAGEMENT LTD 2,713,176$12,589,0000.39%
Bellevue Group AG 4,299,164$19,948,0000.23%
WASATCH ADVISORS LP 8,147,380$37,804,0000.19%
Telemetry Investments, L.L.C. 17,500$81,0000.13%
View complete list of ESPERION THERAPEUTICS INC NE shareholders